FDA Nomination Pulled: White House Drops Heidi Overton Before Senate Vote

Nomination withdrawn
The administration has ended Overton’s nomination for FDA commissioner, according to people familiar with the decision. The White House did not provide a reason in the report. President Trump had selected Overton for the post. The decision means the scheduled committee vote on her nomination will not proceed as planned.
Senate vote was scheduled
The Senate health committee had been set to vote on Overton’s nomination Wednesday. The report gives no further details about the committee’s next steps.
Report remains developing
The report was published on November 17, 2026, at 8:14 p.m. Eastern time. It said the story would be updated as more information became available. No explanation for the move or information about a replacement nominee was included in the report.
Key points
- The White House withdrew Dr. Heidi Overton’s nomination to lead the FDA.
- A Senate health committee vote had been scheduled for Wednesday.
- The report did not give a reason for the withdrawal.
- Axios first reported the decision.

